{
  "id": [
    "31072216"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "31072216"
  ],
  "pmcid": [
    "PMC6522981"
  ],
  "doi": [
    "10.1080/14756366.2019.1613987"
  ],
  "title": [
    "Structure-based design generated novel hydroxamic acid based preferential HDAC6 lead inhibitor with on-target cytotoxic activity against primary choroid plexus carcinoma."
  ],
  "authorString": [
    "Kassab SE, Mowafy S, Alserw AM, Seliem JA, El-Naggar SM, Omar NN, Awad MM."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Kassab SE"
          ],
          "firstName": [
            "Shaymaa E"
          ],
          "lastName": [
            "Kassab"
          ],
          "initials": [
            "SE"
          ],
          "affiliation": [
            "a Pharmaceutical Chemistry Department, Faulty of Pharmacy , Damanhour University , Damanhour , Egypt."
          ]
        },
        {
          "fullName": [
            "Mowafy S"
          ],
          "firstName": [
            "Samar"
          ],
          "lastName": [
            "Mowafy"
          ],
          "initials": [
            "S"
          ],
          "affiliation": [
            "b Pharmaceutical Chemistry Department, Faculty of Pharmacy , Misr International University , Cairo , Egypt."
          ]
        },
        {
          "fullName": [
            "Alserw AM"
          ],
          "firstName": [
            "Aya M"
          ],
          "lastName": [
            "Alserw"
          ],
          "initials": [
            "AM"
          ],
          "affiliation": [
            "c Basic Research Unit, Department of Research , Children's Cancer Hospital in Egypt , Cairo , Egypt."
          ]
        },
        {
          "fullName": [
            "Seliem JA"
          ],
          "firstName": [
            "Joustin A"
          ],
          "lastName": [
            "Seliem"
          ],
          "initials": [
            "JA"
          ],
          "affiliation": [
            "c Basic Research Unit, Department of Research , Children's Cancer Hospital in Egypt , Cairo , Egypt."
          ]
        },
        {
          "fullName": [
            "El-Naggar SM"
          ],
          "firstName": [
            "Shahenda M"
          ],
          "lastName": [
            "El-Naggar"
          ],
          "initials": [
            "SM"
          ],
          "affiliation": [
            "c Basic Research Unit, Department of Research , Children's Cancer Hospital in Egypt , Cairo , Egypt."
          ]
        },
        {
          "fullName": [
            "Omar NN"
          ],
          "firstName": [
            "Nesreen N"
          ],
          "lastName": [
            "Omar"
          ],
          "initials": [
            "NN"
          ],
          "affiliation": [
            "d Biochemistry Department, Faculty of Pharmacy , Modern University for Technology and Information , Cairo , Egypt."
          ]
        },
        {
          "fullName": [
            "Awad MM"
          ],
          "firstName": [
            "Mohamed M"
          ],
          "lastName": [
            "Awad"
          ],
          "initials": [
            "MM"
          ],
          "affiliation": [
            "e Department of Pharmacology and Toxicology, Faculty of Pharmacy , Helwan University , Cairo , Egypt."
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "1"
      ],
      "volume": [
        "34"
      ],
      "journalIssueId": [
        "2741813"
      ],
      "dateOfPublication": [
        "2019 Dec"
      ],
      "monthOfPublication": [
        "12"
      ],
      "yearOfPublication": [
        "2019"
      ],
      "printPublicationDate": [
        "2019-12-01"
      ],
      "journal": [
        {
          "title": [
            "Journal of enzyme inhibition and medicinal chemistry"
          ],
          "ISOAbbreviation": [
            "J Enzyme Inhib Med Chem"
          ],
          "medlineAbbreviation": [
            "J Enzyme Inhib Med Chem"
          ],
          "NLMid": [
            "101150203"
          ],
          "ISSN": [
            "1475-6366"
          ],
          "ESSN": [
            "1475-6374"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2019"
  ],
  "pageInfo": [
    "1062-1077"
  ],
  "abstractText": [
    "Histone deacetylase 6 (HDAC6) is an attractive target for cancer therapeutic intervention. Selective HDAC6 inhibitors is important to minimise the side effects of pan inhibition. Thus, new class of hydroxamic acid-based derivatives were designed on structural basis to perform preferential activity against HDAC6 targeting solid tumours. Interestingly, 1-benzylbenzimidazole-2-thio-N-hydroxybutanamide 10a showed impressive preference with submicromolar potency against HDAC6 (IC50 = 510 nM). 10a showed cytotoxic activity with interesting profile against CCHE-45 at (IC50 = 112.76 µM) when compared to standard inhibitor Tubacin (IC50 = 20 µM). Western blot analysis of acetylated-α-tubulin verified the HDAC6 inhibiting activity of 10a. Moreover, the insignificant difference in acetylated-α-tubulin induced by 10a and Tubacin implied the on-target cytotoxic activity of 10a. Docking of 10a in the binding site of HDAC6 attributed the activity of 10a to π-π stacking with the amino acids of the hydrophobic channel of HDAC6 and capture of zinc metal in bidentate fashion. The therapeutic usefulness besides the on-target activity may define 10a as an interesting safe-lead inhibitor for future development."
  ],
  "affiliation": [
    "a Pharmaceutical Chemistry Department, Faulty of Pharmacy , Damanhour University , Damanhour , Egypt."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "research-article",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cell Line, Tumor"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Carcinoma"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Choroid Plexus Neoplasms"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Hydroxamic Acids"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "CS"
                  ],
                  "qualifierName": [
                    "chemical synthesis"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "CH"
                  ],
                  "qualifierName": [
                    "chemistry"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antineoplastic Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "CS"
                  ],
                  "qualifierName": [
                    "chemical synthesis"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "CH"
                  ],
                  "qualifierName": [
                    "chemistry"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Drug Screening Assays, Antitumor"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cell Proliferation"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Molecular Structure"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Structure-Activity Relationship"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Dose-Response Relationship, Drug"
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Drug Design"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Histone Deacetylase Inhibitors"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "CS"
                  ],
                  "qualifierName": [
                    "chemical synthesis"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "CH"
                  ],
                  "qualifierName": [
                    "chemistry"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Histone Deacetylase 6"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AI"
                  ],
                  "qualifierName": [
                    "antagonists & inhibitors"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Cytotoxicity",
        "Benzimidazole",
        "Choroid Plexus Carcinoma",
        "On-target Activity",
        "Acute Promyeloblastic Leukemia",
        "Preferential Hdac6 Inhibitor",
        "Acetylated-α-tubulin"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Antineoplastic Agents"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Hydroxamic Acids"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "HDAC6 protein, human"
          ],
          "registryNumber": [
            "EC 3.5.1.98"
          ]
        },
        {
          "name": [
            "Histone Deacetylase Inhibitors"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Histone Deacetylase 6"
          ],
          "registryNumber": [
            "EC 3.5.1.98"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC6522981?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC6522981"
          ]
        },
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1080/14756366.2019.1613987"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "Y"
  ],
  "citedByCount": [
    "0"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2019-06-10"
  ],
  "dateOfCreation": [
    "2019-05-11"
  ],
  "firstIndexDate": [
    "2019-05-11"
  ],
  "dateOfRevision": [
    "2019-06-13"
  ],
  "firstPublicationDate": [
    "2019-12-01"
  ]
}